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Abstract
Background: Astrocytes play a major role in preserving and restoring structural and physiological integrity following 
injury to the nervous system. After peripheral axotomy, reactive gliosis propagates within adjacent spinal segments, 
influenced by the local synthesis of nitric oxide (NO). The present work investigated the importance of inducible nitric 
oxide synthase (iNOS) activity in acute and late glial responses after injury and in major histocompatibility complex 
class I (MHC I) expression and synaptic plasticity of inputs to lesioned alpha motoneurons.
Methods: In vivo analyses were carried out using C57BL/6J-iNOS knockout (iNOS-/-) and C57BL/6J mice. Glial response 
after axotomy, glial MHC I expression, and the effects of axotomy on synaptic contacts were measured using 
immunohistochemistry and transmission electron microscopy. For this purpose, 2-month-old animals were sacrificed 
and fixed one or two weeks after unilateral sciatic nerve transection, and spinal cord sections were incubated with 
antibodies against classical MHC I, GFAP (glial fibrillary acidic protein - an astroglial marker), Iba-1 (an ionized calcium 
binding adaptor protein and a microglial marker) or synaptophysin (a presynaptic terminal marker). Western blotting 
analysis of MHC I and nNOS expression one week after lesion were also performed. The data were analyzed using a 
two-tailed Student's t test for parametric data or a two-tailed Mann-Whitney U test for nonparametric data.
Results: A statistical difference was shown with respect to astrogliosis between strains at the different time points 
studied. Also, MHC I expression by iNOS-/- microglial cells did not increase at one or two weeks after unilateral axotomy. 
There was a difference in synaptophysin expression reflecting synaptic elimination, in which iNOS-/- mice displayed a 
decreased number of the inputs to alpha motoneurons, in comparison to that of C57BL/6J.
Conclusion: The findings herein indicate that iNOS isoform activity influences MHC I expression by microglial cells one 
and two weeks after axotomy. This finding was associated with differences in astrogliosis, number of presynaptic 
terminals and synaptic covering of alpha motoneurons after lesioning in the mutant mice.
Background
Nitric oxide (NO) is a gaseous free radical generated in
most cells as a result of a diverse range of stimuli. This
molecule may show protective effects in the nervous sys-
tem, although pathologically elevated levels result in
cytotoxicity. There are three major forms of enzyme that
synthesize NO from L-arginine: the so-called NOS (nitric
oxide synthases), with a 50-60% sequence homology
between species [1]; neuronal (nNOS or NOS I) and
endothelial (eNOS or NOS III) types, comprising the
constitutive isoforms; and finally the inducible type
(iNOS or NOS II). A fourth subtype of NOS (mtNOS) is
an isoform of nNOS, and has been found in the inner
mitochondrial membrane of several tissues including
those of the liver, brain, heart and muscles [2,3].
The NO molecule has been implicated in several pro-
cesses such as brain regulation [4,5], liver microcircula-
tion [6], neuronal regeneration [7-9], neuronal damage
[10], elimination of misdirected axons [11] and synaptic
plasticity [12]. However, in recent years researchers have
noted a dual role for NO, acting either as a pro-apoptotic
mediator [13] or as an anti-apoptotic agent [14,15]. NO
c a n  h a v e  a  p r o t e c t i v e  e f f e c t  o n  d o r s a l  r o o t  g a n g l i o n
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(DRG) neurons in vitro via inhibition of Bax and caspases
[16]. On the other hand, systemic NO inhibition by Nω-
nitro-L-arginine (NOLA) or N-nitro-L-arginine methyl
ester (L-NAME) results in delayed axonal degeneration
after intraorbital optic nerve transection [17].
Peripheral nerve lesions, such as sciatic nerve transec-
tion, induce upregulation of all NOS isoforms, as demon-
strated by NADPH-diaphorase histochemistry [18], NOS
immunohistochemistry [19,20] and in situ hybridization
[21]. Such increases in NOS expression result in
enhanced expression of NO in the nerve microenviron-
ment. Nevertheless, retrograde changes in response to
peripheral axotomy also affect motoneuron cell bodies
present in the spinal cord microenvironment. Second-
arily to this, a prominent glial reaction develops in the
spinal segments affected by a peripheral lesion, contrib-
uting to an intense rearrangement of synapses.
The mechanisms underlying neuron/neuron and neu-
ron/glial communication after such lesioning remain
poorly understood. Recently, the expression of the class I
major histocompatibility complex (MHC I) was related to
synaptic plasticity and to astrogliosis after peripheral
nerve transection [22-26]. Interestingly, A/J mice, which
present a greater axonal regeneration potential [27,28],
also display more robust glial fibrillary acidic (GFAP) and
ERM (ezrin-radixin-miosin) protein expression in spinal
cord after axotomy, when compared to other strains of
mice [24-26]. The Ca2+-calmodulin-independent isoform,
iNOS, is expressed by astrocytes, macrophages and
microglia following immunological or inflammatory
stimulation [29-31]. This isoform has also been reported
in other cells such as human hepatocytes [32] and rat vas-
cular smooth muscle cells [33]. After axotomy, knockout
mice lacking iNOS show slower Wallerian degeneration
and fewer regenerating myelinated fibers [9]. Also, the
absence of inducible nitric oxide at the site of the lesion
can be related to subsequent neuropathic pain and
decreased functional hind limb recovery. It has been sug-
gested that astrocytes and microglia may be implicated in
such an outcome [34,35].
Taking into account the profound acute changes in spi-
nal cord circuits following a peripheral lesion, it is possi-
ble that NO may be involved in signaling pathways that
induce MHC I upregulation by neurons and glia. Thus
the present study investigated the process of synaptic
plasticity after peripheral axotomy in the spinal cord of
knockout mice lacking the inducible form of nitric oxide
synthase (iNOS-/-). Different techniques (immunohis-
tochemistry, western blotting and transmission electron
microscopy) were used to investigate classical MHC I
expression as well as glial responses following peripheral
nerve injury. It is proposed that iNOS expression influ-
ences the outcome of the synaptic plasticity process in
spinal cord, which is correlated with reduced MHC I
expression.
Methods
Animals
For the present study, 30 6- to 8-week-old iNOS-/- http://
jaxmice.jax.org/strain/002596.html and 30 C57BL/6J age-
matched wild type (WT) mice (~25.0 g body weight)
were used. The animals were obtained from the Multidis-
ciplinary Center for Biological Investigation (CEMIB/
Unicamp) and were housed with a 12 h light/dark cycle
and free access to food and water. The study was
approved by the Institutional Committee for Ethics in
Animal Experimentation (CEEA/IB/Unicamp, proc.
1172-1), and all the experiments were carried out accord-
ing to the guidelines of the Brazilian College for Animal
Experimentation (COBEA). The mice from both strains
were subjected to unilateral sciatic nerve transection as
described below. The unlesioned sides were used as con-
trols.
Surgical procedures and tissue preparation
The mice were anesthetized with a mixture of Kensol
(Xylazin, König, 10 mg/Kg) and Vetaset (Cetamin, Fort
Dodge, 50 mg/Kg; 1:1, 0.12 ml/25 g, i.p.), and subjected to
left sciatic nerve transection at level of the obturator ten-
don. A 2-mm-long segment of the distal stump was
removed to avoid regeneration. Muscle and skin planes
were sutured, and the animals allowed to survive for 1 or
2 weeks. All mice were sacrificed using an overdose of
anesthetic, subjected to transcardial perfusion with 0.1 M
PBS (phosphate buffered saline, 20 ml, pH 7.4) and fixed
either in 10% formaldehyde in PB (phosphate buffer) for
immunohistochemistry or with Karnovsky fixative (2.5%
glutaraldehyde and 1.0% paraformaldehyde in 0.1 M
phosphate buffer pH 7.4) for electron microscopy. Spinal
cord segments L4-L6 were dissected out and either fro-
zen (for immunohistochemistry), embedded in resin (for
electron microscopy) or processed for western blotting
analysis (non-fixed tissue).
Immunohistochemistry
Lumbar spinal cords from animals sacrificed one or two
weeks after axotomy were frozen at -40°C for cryostat
sectioning (12 μm thickness). In the primary incubation,
the following antisera were used: goat anti-GFAP (1:500,
Santa Cruz Biotechnology, USA), rabbit anti-Iba-1 (anti-
body against the ionized calcium binding adaptor pro-
tein, 1:1000, Wako, USA [36]), rat anti-classical MHC I
(ER-Hr52, which recognizes H2-Kb and H2-Db, the two
classical MHC I in C57BL6/J mice, 1:200, BMA Biomedi-
cals, Switzerland), mouse anti-nNOS (1:200, BD Biosci-
ences, USA), mouse anti-iNOS (1:200, Santa Cruz
Biotechnology, USA), mouse anti-NeuN (antibodyEmirandetti et al. Journal of Neuroinflammation 2010, 7:31
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against neuronal nuclear antigen, 1:600, Chemicon, USA)
or rabbit anti-synaptophysin (an antibody against a pro-
tein present in the membrane of synaptic vesicles 1:200,
Dako, Denmark). The antibodies were diluted in a solu-
tion containing BSA and Triton x-100 in 0.01 M PBS and
the slides were post-fixed in cold acetone for 30 seconds
prior to the classical MHC I incubation; the sections were
incubated overnight at 4°C in a moist chamber. After
rinsing in 0.01 M PBS, sections were incubated with Cy3,
Cy2 or FICT-conjugated secondary antisera (1:250, Jack-
son ImmunoResearch) for 45 min in a moist chamber at
room temperature. The slides were then rinsed in PBS,
mounted in a glycerol/PBS (3:1) mixture and observed
using an inverted fluorescence microscope (Eclipse
TS100, Nikon) equipped with a high resolution camera
(DXM 1200F, Nikon). For quantitative measurements, the
lesioned segments were first identified by the presence of
decreased synaptophysin immunolabeling in the
motoneuron microenvironment, combined with an
increased glial reaction. Three alternate sections (ipsi-
and contralateral sides of the spinal cord) from each ani-
mal (n = 10 for each group) were then used to capture
images from the ventral horn at a final magnification of
x200, always maintaining all settings unchanged. Because
of the reduced area occupied by alpha motoneurons in
the dorsolateral region of the ventral horn and because
several sections were used to perform immunohis-
tochemistry, 10 mice per group were used. However, only
5 animals per group were allocated for the quantitative
analysis. Quantification was performed around the axo-
tomized motoneurons using the enhance contrast and
density slicing feature of IMAGEJ software (version
1.33u, National Institute of Health, USA). The integrated
density of pixels (sum of the gray values of each pixel in a
determined area) around each motoneuron identified in
the lateral motor nucleus was measured in eight circular
areas from each side, as shown in Figure 1R. This quanti-
fication method measures the intensity of fluorescence in
a given image, and has been used in previous studies [23-
26]. A lesioned/unlesioned ratio for the integrated den-
sity of pixels was calculated for each section (axotomy
groups) and then a mean value was calculated for each
spinal cord. The data are represented as mean ± standard
deviation (SD).
Western blotting
For quantification of MHC class I and nNOS expressions,
3-mm portions of lumbar spinal cord (L4-L6 segments)
were cut from the right (contralateral) and left (ipsilateral
to the axotomy) sides. All specimens were sonicated in
Rippa buffer protein extraction medium (150 mM NaCl,
50 mM Tris pH 8.0, 1 mM PMSF, 1 mM EDTA, 0.5% Na-
deoxycholate acid, 0.1% SDS and 1% Triton X-100) for 1
min. Total protein concentration was measured using
Bio-Rad Bradford's protein assay.
Western blotting was performed after submitting 100
μg (MHC class I) or 40 μg (nNOS) of protein extract from
each tissue sample to electrophoresis in 10% (MHC I) or
12.5% (nNOS) polyacrylamide gels under reducing condi-
tions, and electric transfer to nitrocellulose membranes
(Hybond-ECL; Amersham Biosciences, Chalfont St.
Giles, United Kingdom). The membranes were blocked
for 1 h with 1% or 5% nonfat milk powder in Tris buffered
saline plus 0.2% Tween 20 (TBS-T) at room temperature,
with agitation. Rat anti-MHC class I (ER-Hr52 monoclo-
nal, 1:500, Peninsula, USA), mouse anti-nNOS (monoclo-
nal, 1:500, Santa Cruz Biotechnology, USA) or rabbit
anti-beta actin (polyclonal, 1:5000, Abcam, USA) anti-
bodies were diluted in 0.1 or 1% nonfat milk powder in
TBS-T and incubated overnight at 4°C. After the primary
antisera, three TBS-T washes were carried out and either
HRP-conjugated rabbit anti-rat, rabbit anti-mouse or
goat anti-rabbit IgG antibody (1:2500, in TBS-T, Zymed
Laboratories, USA) - according to the host of the primary
antibody - was added for 1 h at room temperature, with
agitation. After a further set of washes, detection of the
labeling was achieved by chemiluminescence (Perkin-
Elmer, Waltham, USA). Band intensity was determined
by densitometry using ImageJ Software (version 1.33u,
National Institute of Health, USA).
Electron microscopy
Lumbar spinal cords (n = 5 for each group) were dis-
sected out and stored overnight in fixative at 4°C. The
specimens were then trimmed, osmicated, dehydrated,
and embedded in Durcupan (Fluka). Ultrathin sections
from the L4-L6 segments were collected on formvar-
coated copper grids, counterstained with 4% uranyl ace-
tate and lead citrate, and examined under a transmission
electron microscope operating at 60 KV (Leo 906,
ZEISS). Neurons with large cell bodies (~35 μm in diame-
ter), found in the sciatic motoneuron pool and cut in the
nuclear plane, were identified as α-motoneurons by the
presence of C-type nerve terminals and chromatolysis
(axotomized side). The cell surfaces were then sequen-
tially digitalized at a magnification of 12.930X with a
video camera connected to a computer, and the images
mounted together using vectorial software. Synaptic ter-
minals apposing the motoneuron somata were identified
and their numbers per 100 μm of cell membrane, as well
as the membrane covering of all the terminals (calculated
in percent of membrane length), determined using the
measurement tool of Image Tool software (Version 3.0,
The University of Texas Health Center, USA). The termi-
nals were typed as F-type (with flattened synaptic vesi-
cles), S-type (with spherical synaptic vesicles) or C-type
(with a sub synaptic cistern), according to the procedureEmirandetti et al. Journal of Neuroinflammation 2010, 7:31
http://www.jneuroinflammation.com/content/7/1/31
Page 4 of 16
Figure 1 Iba-1 and NeuN double-labeling in C57BL6/J and iNOS-/- mice, one and two weeks after axotomy. Observe the strong upregulation 
of Iba-1 labeling in C57BL6/J (WT, F) and iNOS-/- (N) one week after lesion, as compared to the unlesioned side (B and J). Two weeks after axotomy, 
the microglial reaction decreased (H and P). The microglia presented in close apposition to axotomized motoneurons (G and O). (A and I) NeuN 
labeling on the contralateral side of C57BL6/J and iNOS-/- mice, respectively. (E and M) NeuN labeling on the ipsilateral side of C57BL6/J and iNOS-/- 
mice, respectively. (C and K) Iba-1 and NeuN double-labeling in the unlesioned side of C57BL6/J and iNOS-/- mice. (D and L) Iba-1 labeling on the 
unlesioned side of C57BL6/J and iNOS-/- mice, two weeks after axotomy. (Q) Graph representing quantification of the integrated density of pixels 
(×103) for Iba-1 immunohistochemistry in the neuropil of the unlesioned and lesioned sides, one (1 w) and two (2 w) weeks after axotomy. * = p < 
0.05 (Mann-Whitney U test). Scale bar = 50 μm. (R) Schematic representation of the sciatic nerve pool in the ventral horn of spinal cord. One motoneu-
ron is shown in detail with apposed pre-synaptic terminals. The dashed circles represent areas where measurements of the integrated density of pixels 
were performed.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
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described by Conradi [37]. The distance between consec-
utive nerve terminals covering the motoneurons was also
determined. A total of 30 sciatic α-motoneurons (two
neurons per animal in three groups of five animals: iNOS-
/- axotomized, WT axotomized and WT unlesioned) were
quantified. The data were represented as the mean ±
standard deviation (SD).
Statistical analysis
The data were analyzed using a two-tailed Student's t test
for parametric data or a two-tailed Mann-Whitney U test
for nonparametric data at p < 0.05 (*), p < 0.01 (**), and p
< 0.001 (***). The statistical analyses and graph plotting
were done by using tools from a GraphPad Prism4 pro-
gram.
Results
Glial reaction and classical MHC I spinal expression in the 
absence of inducible nitric oxide one and two weeks after 
lesioning
The effects of sciatic nerve transection on microglial
reaction were assessed with quantitative measurements
of immunoreactivity around the spinal cord motor
nucleus one and two weeks after lesion, using anti-Iba-1
antiserum (antibody against the ionized calcium binding
adaptor protein, a microglial marker [36]; Figure 1).
Microglial cells were not reactive in the areas surround-
ing NeuN-labeled motoneurons on the unlesioned side
(Figures. 1C and 1K) and quantitative analysis showed no
statistical differences between C57BL6/J and iNOS-/-
mice (C57BL6/J, 3.13 × 103 ± 0.62; iNOS-/-, 3.20 ± 0.47;
Figure 1Q), indicating that both strains displayed equiva-
lent basal expression of the referred protein (also seen in
Figures 1B and 1J). However, there was an increase in Iba-
1 expression on the lesioned side of both strains one and
two weeks after axotomy (Figures 1F, N, H and 1P). It is
important to emphasize the close relationship between
the axotomized α-motoneurons and the reactive micro-
glia, as depicted in figures 1G and 1O, respectively. The
integrated density of pixels in the lesioned side was also
determined and showed statistical differences between
the two studied time points in both strains (C57BL6/J one
week, 8.43 × 103 ± 0.47; two weeks, 4.70 × 103 ± 0.73, p <
0.05 and iNOS-/- one week, 8.99 × 103 ± 1.48; two weeks,
4.08 × 103 ± 0.21, p < 0.05, Figure 1Q).
In order to analyze expression of classical MHC I in
ventral horn, Iba-1 and MHC I double labeling was per-
formed. Such immunolabeling also assured that the spi-
nal segments analyzed contained lesioned α-
motoneurons (Figure 2). Lesioning did not result in any
significant increase of MHC I expression on the unle-
sioned side (not shown). However, at both one and two
weeks after axotomy the C57BL6/J mice showed signifi-
cant upregulation of MHC I protein in the surroundings
of the motoneurons on the lesioned side (Figures 2B and
2D). This difference in MHC I expression by wild type
microglial cells at different time points after lesioning is
shown in Figure 2J (C57BL6/J one week, 6.51 × 103 ± 0.49;
two weeks, 9.06 × 103 ± 1.43, p < 0.05). Interestingly, the
elevated expression of MHC I in wild type mice co-local-
ized with Iba-1 labeling (Figure 2C). Also, MHC I expres-
sion in iNOS knockout mice was not increased at either 7
or 21 days after axotomy (Figures 2F and 2H), indicating
that the absence of MHC I expression in iNOS-/- mice
does not represent a delayed response but rather a collat-
eral effect of the gene knockout. Western blot analysis
confirmed the data obtained one week after lesioning and
is depicted in Figure 2I (C57BL6/J 3.81 ± 2.05; iNOS-/-
2.19 ± 0.81, p < 0.05, contralateral; C57BL6/J 5.98 ± 2.23;
iNOS-/- 2.85 ± 1.14; p < 0.01, ipsilateral).
The level of astroglial reaction one and two weeks after
axotomy was also studied in iNOS-/- and WT mice by
measuring immunostaining in the neuropil adjacent to
lesioned NeuN-labeled motoneurons (Figure 3). To deter-
mine whether astrocytes could express classical MHC I,
double labeling was performed using antibodies against
GFAP and MHC I (Figure 4). As shown in Figure 4C, no
significant co-localization was obtained.
There was a statistically significant difference in basal
expression of GFAP between the two strains (as shown in
Figures 3B and 3J). C57BL6/J mice displayed stronger
basal labeling for GFAP compared to iNOS-/-  mice
(C57BL6/J, 2.169 × 103 ± 0.11; iNOS-/-, 0.98 × 103 ± 0.14, p
< 0.001; Figure 5Q). However, there was upregulation of
GFAP expression one week (C57BL6/J, 5.01 × 103 ± 0.22;
iNOS-/-, 4.24 × 103 ± 0.80, p < 0.05) and two weeks
(C57BL6/J, 6.01 × 103 ± 0.49; iNOS-/-, 4.76 × 103 ± 0.44, p
< 0.01) after sciatic nerve transection (Figure 3Q). GFAP
labeling was more robust in iNOS-/- mice 14 days after
nerve lesion, as compared to one week post axotomy (p <
0.01, Figure 3Q). It is important to emphasize that the
astroglial reaction presented a diffuse pattern in normal
mice (Figure 3F and 3H), whereas it was restricted to the
surroundings of the sciatic motoneuron pool in iNOS
deficient mice (Figure 3N and 3P).
Loss of inputs to axotomized iNOS-/- spinal α-motoneurons 
is shown by a decrease in synaptophysin labeling
To analyze changes in synaptic activity resulting from
axotomy, quantitative measurements of the expression of
the synaptic protein synaptophysin were made for the sci-
atic motor nuclei of iNOS-/- and C57BL6/J mice. Only
large motoneurons present in the dorsolateral nucleus,
which supplies the distal hind limb muscles, were consid-
ered for analysis. Figures 5A and 5B show similar synap-
tophysin immunoreactivity in ventral horn of WT and
iNOS-deficient mice (Figure 5C). In both cases, a clearEmirandetti et al. Journal of Neuroinflammation 2010, 7:31
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decrease in synaptophysin labeling occurred in the motor
nuclei on the lesioned side, although this reduction was
significantly greater in iNOS-/- as compared to C57BL6/J
mice (C57BL6/J, 0.72 ± 0.05; iNOS-/-, 0.53 ± 0.03, p <
0.05, lesioned/unlesioned side r a t i o ,  F i g u r e  5 E ) .  T h e
scheme shown in Figure 5F indicates the circular areas
(100 μm2 each) used for quantification of immunofluores-
cence. The differential degree of synaptic elimination
observed by immunohistochemistry was further assessed
using transmission electron microscopy, and these results
are described below.
Synaptic elimination, glial reaction and MHC expression are 
not influenced by neuronal nitric oxide synthase isoform 
(nNOS)
An important question to answer was whether the glial
and neuronal events in response to sciatic nerve transec-
tion could be related to differential neuronal expression
of nNOS in C57BL6/J mice after axotomy. For this pur-
Figure 2 Classical MHC I and Iba-1 double-staining in C57BL6/J and iNOS-/- mice, one and two weeks after axotomy. Observe the significantly 
stronger upregulation of MHC I (ER-Hr52) labeling in C57BL6/J (WT) mice one week after lesion (B), which is co-localized with microglial Iba-1 positive 
cells (C). The lesioned side (F) of the spinal cord of iNOS-/- mice shows almost no labeling, (A and E) Iba-1 labeling on the lesioned side of C57BL6/J 
and iNOS-/- mice, respectively. Two weeks after lesioning, ER-HR52 immunolabeling is even stronger than in the acute phase (D). (H) No MHC I labeling 
was seen in the ventral horn of iNOS-/- mice, two weeks after sciatic transection. (I). Western blotting analysis of MHC I expression in spinal cord ventral 
horn ipsi- and contralateral to axotomy. Note the upregulation of MHC I in wild type mice after lesion, which is not observed in iNOS-/- animals. β-Actin 
was used as sample loading control. IL = ipsilateral; CL = contralateral. * = p < 0.05; ** = p < 0.01 (Mann-Whitney U test). (J) Graph representing quan-
tification of the integrated density of pixels for MHC I immunolabeling in the neuropil adjacent to large motoneurons, one (1 w) and two (2 w) weeks 
after axotomy. * = p < 0.05, Student t test. Scale bar = 50 μm.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
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Figure 3 GFAP and NeuN double-labeling in C57BL6/J and iNOS-/- mice, one and two weeks after axotomy. Observe the strong upregulation 
of GFAP labeling in C57BL6/J (WT, F) and iNOS-/- (N) one week after lesion, as compared to the unlesioned side (B and J). The iNOS-/- unlesioned side 
(J) shows milder basal astroglial labeling as compared to control mice. After lesioning the astroglial reaction presented a diffuse distribution surround-
ing the axotomized pool of motoneurons in WT mice (G), and was more concentrated around the motoneurons in iNOS-deficient mice (O). (A and 
I) NeuN labeling on the contralateral side of C57BL6/J and iNOS-/- mice, respectively. (E and M) NeuN labeling on the ipsilateral side of C57BL6/J and 
iNOS-/- mice, respectively. (C and K) GFAP and NeuN double-labeling on the unlesioned side of C57BL6/J and iNOS-/- mice. (H and P) GFAP labeling 
in C57BL6/J and iNOS-/- mice, two weeks after axotomy, lesioned side. (D and L) GFAP labeling in C57BL6/J and iNOS-/- mice, two weeks after axotomy, 
unlesioned side. (Q) Graph representing quantification of the integrated density of pixels for GFAP in the neuropil of the unlesioned and lesioned 
sides, one (1 w) and two weeks (2 w) after axotomy. * = p < 0.05, ** = p < 0.01 and *** = p < 0.001 (Student t test). Scale bar = 50 μm.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
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pose, immunohistochemistry using anti-nNOs antibody
was performed in iNOS-/-  and C57BL6/J spinal cords
(Figure 6). nNOS immunolabeling was observed within
neurons throughout the spinal cord, including large
motoneurons in both wild type and iNOS knockout mice
(Figures 6C and 6D, respectively). Western blot analysis
confirmed the immunolabeling results obtained in situ,
and indicated that axotomy did not result in statistically
significant nNOS activity upregulation (Figure 6E). Fig-
ure 6A shows iNOS expression by C57BL6/J glial cells
one week (1 w) after transection. Such up-regulation was
not detectable on the lesioned side, two weeks (2 w) after
axotomy.
Faster synaptic elimination in iNOS-deficient mice after 
lesioning (Figures 7, 8 and 9)
To better understand the different processes involved
during synaptic elimination in iNOS-deficient and WT
mice, a thorough ultrastructural analysis of inputs to α-
motoneurons in the sciatic nerve pool was carried out.
The general ultrastructure appeared identical for both
mice strains studied. The total synaptic covering, which
represents the motoneuron body surface in contact with
presynaptic terminals, revealed the same general density
of synapses in unlesioned iNOS-/- and C57BL6/J mice, as
shown in Figure 7A (C57BL6/J, 52.43% ± 0.74%; iNOS-/-,
46.28% ± 4.38%). However, one week after axotomy, the
synaptic elimination process differed significantly when
the strains were compared (C57BL6/J, 31.63% ± 0.57%;
iNOS-/-, 24.61% ± 1.69%, p < 0.01). Moreover, total counts
of terminals apposed to the motoneuron surface revealed
a smaller number of boutons per 100 μm on the right side
in the absence of iNOS (C57BL6/J, 36.08 ± 3.87; iNOS-/-,
26.89 ± 0.93, p < 0.05, Figure 8C). These values were even
lower after axotomy (C57BL6/J, 22.58 ± 1.39; iNOS-/-,
13.43 ± 1.27, p < 0.01, Figure 8C). The results described
above were further investigated under TEM in order to
determine whether there was any qualitative difference in
type of preserved inputs in the two referred strains. As
described earlier [37], there are two main categories of
synaptic terminals on motoneurons, which can be typed
according to the shape of their synaptic vesicles. Type S
terminals, with spherical vesicles, mostly contain the
excitatory neurotransmitter glutamate, although a small
proportion of large S terminals are cholinergic (C)
[38,39]. When observed under TEM, the F terminals con-
tain flattened or pleomorphic vesicles filled with glycine
and/or GABA [40,41], and work as inhibitory inputs.
Qualitative analysis of F, S and C boutons, presented in
Figures 7 and 8, reveals that a greater number of F termi-
nals were preserved in apposition to sciatic motoneurons
in C57BL6/J mice as compared to iNOS-/- mice (C57BL6/
J, 15.12 ± 1.18; iNOS-/-, 8.78 ± 1.00, p < 0.01, Figure 8D)
one week after cutting the sciatic nerve. S terminals were
Figure 4 Classical MHC I and GFAP double-staining in C57BL6/J and iNOS-/- mice, one week after axotomy. Observe that GFAP labeling in 
C57BL6/J (WT) mice is not co-localized with MHC I- (ER-Hr52) positive cells (C). Again, axotomized iNOS-/- mice did not express classical MHC I (E). (A 
and D) GFAP labeling on the lesioned side of C57BL6/J and iNOS-/- mice, respectively. Scale bar = 50 μm.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
http://www.jneuroinflammation.com/content/7/1/31
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Figure 5 Synaptophysin immunostaining in C57BL6/J and iNOS-/- mice, one week after unilateral axotomy. Note that one week after lesioning, 
there was a stronger decrease in labeling especially in the areas surrounding the motoneurons. This decrease was more intense in iNOS-/- mice (D) 
than in C57BL6/J mice (B). (A and C) Unlesioned side of C57BL6/J and iNOS-/- mice, respectively. The dashed circle indicates the motor nucleus con-
taining the alpha motoneurons. (E) Graph representing quantification of the integrated density of pixels in the neuropil adjacent to large motoneu-
rons. * = p < 0.05 (Student t test). Scale bar = 50 μm.Figure 6 iNOS and nNOS labeling in C57BL6/J and iNOS-/- mice, one and two weeks after unilateral axotomy. (A) positive iNOS labeling within 
the motor nucleus in C57BL6/J (WT) one week after axotomy (1 w). The lesioned side (B) of the spinal cord of WT mice shows no labeling two weeks 
after axotomy (2 w). (C and D) nNOS immunolabeling in C57BL6/J and iNOS-/- ventral horn one week after lesioning, respectively. (E) Western blot 
analysis of nNOS expression in iNOS knockout mice and WT mice. Observe the absence of statistically significant nNOS upregulation after peripheral 
axotomy as well as the similar expression of such protein in both strains. β-Actin was used as sample loading control. IL = ipsilateral; CL = contralateral. 
Scale bar = 50 μm.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
http://www.jneuroinflammation.com/content/7/1/31
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Figure 7 Synaptic covering obtained by a detailed analysis of inputs in apposition to the surface of sciatic motoneurons. (A) Percentage of 
absolute retraction of nerve terminals from apposition to the postsynaptic membrane in the different mice strains. One week after axotomy, a signif-
icant loss of covering can be seen in iNOS-/- mice as compared to C57BL6/J mice. (B - D) Percentage of synaptic covering by F-, S- and C-terminals on 
the unlesioned and lesioned sides. Note that after injury the iNOS-/- mice presented a greater loss of F- type terminals than the WT mice. * = p < 0.05 
and ** = p < 0.01 (Mann-Whitney U test).Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
http://www.jneuroinflammation.com/content/7/1/31
Page 12 of 16
preserved to a smaller degree in normal mice (C57BL6/J,
6.27 ± 1.52; iNOS-/-, 3.99 ± 0.68, p < 0.05, Figure 8G).
However, in terms of F synaptic covering, C57BL6/J mice
displayed the greatest values after transection, as shown
in Figure 7B (C57BL6/J, 20.79% ± 2.71%; iNOS-/-, 16.13%
± 1.64%, p < 0.05).
Figure 9A represents the normal pattern of terminal
distribution along the motoneuron surface in WT mice.
After axotomy, the gaps between clusters of boutons
tended to increase due to selective retraction of inputs, as
shown in Figure 9B. However, in the absence of iNOS, the
number of gaps was decreased (Figure 9C) as a conse-
quence of a diminished number of basal terminals char-
acteristic of this strain, as previously shown in Figure 9A.
The remaining terminals were usually close together, so
that the general pattern of gap distribution was main-
tained. One week after axotomy, iNOS-/- mice displayed a
disturbed terminal distribution pattern, represented by a
smaller number of gaps. In addition it was possible to find
much longer gaps in the iNOS-/- mice when compared to
the C57BL6/J mice (between 16 and 30 μm long), indicat-
ing that the transgenic mice developed a stronger reac-
tion to the peripheral lesion.
On the whole, these results with respect to synaptology
may be interpreted to indicate that the acute response to
injury is milder in C57BL6/J mice than in mice lacking
inducible nitric oxide synthase, both in terms of synaptic
retraction and terminal apposition surface.
Discussion
It has been reported that neurons and glial cells in the
CNS can express MHC class I complex in response to dif-
ferent stimuli, including neurodegenerative diseases such
as Huntington's disease, Parkinson's disease, autism and
schizophrenia [42,43], and also following peripheral
nerve axotomy [44,24,26]. By demonstrating that expres-
Figure 8 Quantitative ultrastructural analyses of the number of synaptic terminals apposed to the surface of motoneurons after axotomy. 
(A and E) Representative micrographs of the surface of unlesioned motoneurons from C57BL6/J and iNOS-/- mice strains, respectively. One week after 
peripheral lesion, C57BL6/J mice show a few synaptic terminals detached from the surface of lesioned motoneurons (B). Such detachment occurred 
to a greater degree in the ventral horn of the iNOS knockout strain (F). Observe the comparatively lower degree of synaptic covering in iNOS-/- mice 
as compared to C57BL6/J mice. DT = detached terminal, T = apposed terminal, Mt = motoneuron. The black arrows indicate the location of motoneu-
ron membrane surfaces from which synaptic terminals were detached. (C) Graph of the total number of synaptic terminals per 100 μm of motoneuron 
membrane in lesioned and unlesioned neurons. Observe that unlesioned iNOS-/- mice show greater synaptic elimination as compared to WT. This 
difference is even higher after axotomy. (F, G and H) Graphs of F-, S- and C-terminal numbers per 100 μm of motoneuron membranes, respectively. 
A greater loss of F-type terminals can be seen one week after axotomy in iNOS-/- mice. * = p < 0.05 and ** = p < 0.01 (Mann-Whitney U test). Scale bar 
= 1 μm.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
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sion of this immune molecule occurs within the CNS,
such findings challenged the prevailing view that the
brain is "immunoprivileged" [45,46]. This process is not
only restricted to MHC I molecules, but is also valid for
C1q, the initiating protein in the classical complement
cascade, which mediates CNS synapse elimination during
development [47].
Lindå et al. [44] used in situ hybridization techniques to
show that motoneurons express β2-microglobulin mRNA
(a co-subunit of the MHC class I complex) in response to
sciatic nerve transection. In addition, a major contribu-
tion to identify putative signaling molecules in synaptic
plasticity events was provided by Huh et al. [48], who
demonstrated that functional expression of immune-rec-
ognition MHC class I molecules is linked to the process
of synaptic elimination in the developing CNS.
More recently, Oliveira et al. [23] proposed a role for
classical MHC I molecules in the mechanisms of synaptic
plasticity after peripheral nerve axotomy. Using β2-
microglobulin- and TAP I- (required for loading peptides
onto the MHC I in the endoplasmic reticulum) knockout
mice, they found that such immune molecules were
involved in maintenance of inhibitory inputs after lesion-
ing, leading to a significant detachment of glycine/
GABA-containing synapses from the cell bodies of
transected motoneurons. In addition, Goddard et al. [49]
showed that MHC I proteins are co-localized postsynap-
tically with PSD-95 in dendrites of hippocampal neuronal
cells. Earlier studies also showed that neurons express the
Figure 9 Graphs showing frequency distributions of gaps between terminals along the motoneuron membrane. The general gap distribution 
was retained in both strains one week after lesion indicating that, apart from differences regarding number and covering of terminals, synaptic elim-
ination occurred in such a way that clusters of boutons were preserved. (A and B) Graph of the number of gaps between apposed terminals per length 
of membrane (μm) of C57BL6/J (WT) mice on the unlesioned and lesioned sides, respectively. (C and D) Graph of the number of gaps between ap-
posed terminals per length of membrane (μm) of iNOS-/- mice on the unlesioned and lesioned sides, respectively.Emirandetti et al. Journal of Neuroinflammation 2010, 7:31
http://www.jneuroinflammation.com/content/7/1/31
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MHC I complex, not only after axotomy [50,51], but also
during the course of viral or parasitic infections [35,52]
and exposure to cytokines [53]. Consequently, it is possi-
ble that the present findings indicate that the underlying
mechanisms responsible for presentation of classical
MHC I on the cell surface can be linked to a complex cas-
cade of reactions in which other immune molecules and
cells may be involved.
Regardless of the initial stimulus, a common response
leading to NO synthesis is the upregulation of inflamma-
tory cytokines such as interferon gamma, a potent MHC I
inducer. Following peripheral lesioning, production of
N O  i n f l u e n c e s  t h e  e x p r e s s i o n  o f  M H C  I  i n  t h e  C N S
microenviroment, affecting the synaptic plasticity pro-
cess. The present results are consistent with this hypothe-
sis, since iNOS-/- mice displayed significantly reduced
expression of MHC I one and two weeks after lesioning.
T h i s  i s  r e l e v a n t  t o  t h e  r e g e n e r a t i v e  o u t c o m e  b e c a u s e
C57BL6/J mice, which express reduced amounts of classi-
cal MHC I compared to A/J animals, show decreased
axonal growth in regenerating peripheral nerve and a
delayed return of peripheral nerve function [26].
Along with the neuronal response to injury, the glial
reaction also plays an important role in synaptic plasticity
of the CNS after injury and, to assess this, actin-binding
proteins have previously been used as effective microglial
markers in immunohistochemistry [36]. Although the
microglial reaction in our study did not differ between
the two mice strains, MHC I protein was co-localized
with the Iba-1 marker, indicating that microglia upregu-
late such molecules soon after axotomy. As noted previ-
ously, both microglial and astroglial cells may be
implicated in synaptic elimination after neural damage
[9,34,54,55]. In a previous study, the present authors
showed that the increased astroglial reaction may be
related to a greater stripping of synaptic boutons found in
A/J mice [25]. In this case, the normal activity of iNOS
could lead to astrogliosis and the expression of MHC I.
Conversely, a milder GFAP expression on both the unle-
sioned and lesioned sides of iNOS-/- mice, as compared to
WT mice (in vivo as well as in vitro), could contribute to
the decreased synaptic retraction observed herein. In
fact, iNOS knockout mice showed a significantly
decreased number of terminals per 100 μm of motoneu-
ron membrane on the contralateral (unoperated) side,
reinforcing the idea that iNOS molecules could be
involved in the mechanism of synapse refinement and
plasticity.
The results obtained in the present study reinforce the
importance of the MHC I expression by neurons and
reactive glia after peripheral injury, and indicate that
microglial cells respond to most glial expression of such
molecules. A role for microglia in the synaptic elimina-
tion process has been suggested previously as a result of
ultrastructural studies. Nonetheless, secondarily acti-
vated astrocytes may contribute to maintenance of the
synaptic elimination process in the acute phase after
injury, since their cytoplasmic processes interpose
between retracted pre-synaptic terminals and the
motoneuron cell membrane.
NO production in the CNS is related to an increasingly
diverse variety of responses that range from intercellular
signaling to the necrotic death of cells and the response to
invading pathogens. On the other hand, due to the
absence of selective NOS inhibitors, it has been difficult
to assign specific roles to the different isoforms. NOS-2,
or iNOS, is an enzyme capable of producing a continuous
flux of NO in the presence of adequate substrate and co-
factors. It is expressed in most cells after induction by
immunologic and inflammatory stimuli [56]. The present
study demonstrates that sciatic nerve transection induces
different levels of H2-Db and -Kb expression in C57BL6/J
and iNOS-/- mice. The iNOS isoform is expressed by
astrocytes, macrophages and microglia, following an
immunological or inflammatory stimulation [29,31,57].
Conclusion
In conclusion, the present study shows that knockout
mice for the inducible form of NOS display decreased
expression of MHC I after lesioning and greater synaptic
elimination after peripheral axotomy. Such changes cor-
relate with increased microglial activity without expres-
sion of MHC I, coupled with reduced astroglial reaction.
These observations are in line with the greater synaptic
loss observed in mutant mice that are unable to express
MHC I [23]. Further studies aimed at increasing local
iNOS activity may investigate upregulation of MHC I
molecules by glial cells, which may increase the possibil-
ity of a better regenerative outcome after injury.
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